Association between venous thromboembolism and perioperative allogeneic transfusion

Archives of Surgery

Volumn 142, Issue 2, 2007, Pages 126-132

  Nilsson, Kent R ^a   Berenholtz, Sean M ^a   Garrett Mayer, Elizabeth ^a   Dorman, Todd ^a   Klag, Michael J ^a   Pronovost, Peter J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; COLORECTAL CANCER; COLORECTAL SURGERY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; EMERGENCY WARD; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TIME SERIES ANALYSIS; VENOUS THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION, AUTOLOGOUS; COLECTOMY; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LENGTH OF STAY; MALE; MARYLAND; MIDDLE AGED; PERIOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; VENOUS THROMBOSIS;

EID: 33847106477     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.142.2.126     Document Type: Article

References (45)

1. Spahn DR, Cassutt M. Eliminating blood transfusions: new aspects and perspectives. Anesthesiology. 2000;93:242-255.
2. Goodnough LT, Brecher ME, Kanter M, AuBuchon J. Transfusion medicine: first of two parts, blood transfusion. N Engl J Med. 1999;340:438-447.
3. Blumberg N, Heal J. Blood transfusion immunomodulation: the silent epidemic. Arch Pathol Lab Med. 1998;122:117-119.
4. Flordal PA, Berggvist D, Burmark US, Ljungstrom KG, Torngren S; Fragmin Multicenter Study Group. Risk factors for major thromboembolism and bleeding tendency after elective general surgical operations. Eur J Surg. 1996;162:783-789.
5. Gray DH, Mackie CE. The effect of blood transfusion on the incidence of deep vein thrombosis. Aust N Z J Surg. 1983;53:439-443.
6. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994;331:1601-1606.
7. Schrag D, Cramer L, Bach P, Cohen AM, Warren JL, Begg CB. Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA. 2000;284:3028-3035.
8. Harmon JW, Tang DG, Gordon TA, et al. Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcomes in colorectal resection. Ann Surg. 1999;230:404-411.
9. Bae H, Westrich GH, Sculco TP, Salvati EA, Reich LM. The effect of preoperative donation of autologous blood on deep-vein thrombosis after total hip arthroplasty. J Bone Joint Surg Br. 2001;83:676-679.
10. Anders MJ, Lifeso RM, Landis M, Mikulsky J, Meinking C, McCracken KS. Effect of preoperative donation of autologous blood on deep-vein thrombosis following total joint arthroplasty of the hip or knee. J Bone Joint Surg Am. 1996;78:574-580.
11. Lawthers AG, McCarthy EP, Davis RB, Peterson LE, Palmer RH, Iezzoni LI. Identification of in-hospital complications from claims data: is it valid? Med Care. 2000;38:785-795.
12. US Department of Labor, Bureau of Labor Statistics. Consumer Price Index: All Urban Consumers, US average: Medical Care 2003. http://www.bls.gov/cpi. Accessed February 17, 2004.
13. Berenholtz SM, Pronovost PJ, Mullany D, et al. Predictors of transfusion for spinal surgery in Maryland, 1997 to 2000. Transfusion. 2002;42:183-189.
14. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46:1075-1079.
15. Charlson ME, Pompei P, Ales KL, MacKenzie C. A new method for classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
16. Nilsson KR, Berenholtz S, Dorman T, et al. Preoperative predictors of blood transfusion in colorectal cancer surgery. J Gastrointest Surg. 2002;6:753-762.
17. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc. 1979;74:829-836.
18. Paterson L, Goldstein H. New statistical methods for analyzing social structures: an introduction to multilevel models. Br Educ Res J. 1991;17:387-393.
19. Royston JP. An extension of Shapiro and Wilks' W test for normality to large samples. Appl Stat. 1982;31:115-124.
20. Wu O, Robertson L, Langhorne P, et al; The Thrombosis: Risk and Assessment of Thrombophilia Screening (TREATS) Study. Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. Thromb Haemost. 2005;94:17-25.
21. White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(suppl 1):14-18.
22. Svensson PJ, Benoni G, Fredin H, et al. Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty. Thromb Haemost. 1997;78:993-996.
23. Carter AE, Eban R. The prevention of postoperative deep venous thrombosis with dextran 70. Br J Surg. 1973;60:681-683.
24. Abu-Rustum NR, Richard S, Wilton A, et al. Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival. Gynecol Oncol. 2005;99:320-326.
25. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699-709.
26. Joyce DE, Nelson DR, Grinnell BW. Leukocyte and endothelial cell interactions in sepsis: relevance of the protein C pathway. Crit Care Med. 2004;32:S280-S286.
27. Schroder J, Kahlke V, Staubach KH, Zabel P, Stuber F. Gender differences in human sepsis. Arch Surg. 1998;133:1200-1205.
28. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1997 through 2000. N Engl J Med. 2003;348:1546-1554.
29. Wichmann MW, Inthorn D, Andress HJ, Schildberg FW. Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med. 2000;26:167-172.
30. Kollef MH, Sharpless L, Vlasnik J, Pasque C, Murphy D, Fraser VJ. The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest. 1997;112:666-675.
31. Crabtree TD, Pelletier SJ, Gleason TG, Pruett TL, Sawyer RG. Gender-dependent differences in outcome after the treatment of infection in hospitalized patients. JAMA. 1999;282:2143-2148.
32. Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Buller HR, Vandenbroucke JP. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet. 1995;346:1593-1596.
33. Godsland IF, Winkler U, Lidegaard O, Crook D. Occlusive vascular diseases in oral contraceptive users: epidemiology, pathology and mechanisms. Drugs. 2000;60:721-869.
34. Rosendaal FR, Helmerhorst F, Vandenbroucke JP. Oral contraceptives, hormone replacement therapy and thrombosis. Thromb Haemost. 2001;86:112-123.
35. Kwaan HC, Wang J. Hyperviscosity in polycythemia vera and other red cell abnormalities. Semin Thromb Hemost. 2003;29:451-458.
36. Marik PE, Sibbald WJ. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA. 1993;269:3024-3029.
37. Riquelme BD, Foresto PG, Valverde JR, Rasia JR. Alterations to complex viscoelasticity of erythrocytes during storage. Clin Hemorheol Microcirc. 2000;22:181-188.
38. Sijpkens YW, Doxiadis II, Mallat MJ, et al. Early versus late acute rejection episodes in renal transplantation. Transplantation. 2003;75:204-208.
39. Gjertson DW. Center and other factor effects in recipients of living-donor kidney transplants. Clin Transpl. 2001:209-221.
40. Zeier M, Dohler B, Opelz G, Ritz E. The effect of donor gender on graft survival. J Am Soc Nephrol. 2002;13:2570-2576.
41. Meier-Kriesche HU, Ojo AO, Leavey SF, et al. Gender differences in the risk for chronic renal allograft failure. Transplantation. 2001;71:429-432.
42. Fabbri A, Bryan AJ, Sharples LD, et al. Influence of recipient and donor gender on outcome after heart transplantation. J Heart Lung Transplant. 1992;11:701-707.
43. Palfi M, Berg S, Ernerudh J, Berlin G. A randomized controlled trial of transfusion-related acute lung injury: is plasma from multiparous blood donors dangerous? Transfusion. 2001;41:317-322.
44. Densmore TL, Goodnough LT, Ali S, Dynis M, Chaplin H. Prevalence of HLA sensitization in female apheresis donors. Transfusion. 1999;39:103-106.
45. Hebert PC, Wells G, Blajchman MA, et al; Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care [published correction appears in NEngl J Med. 1999;340:1056]. NEngl J Med. 1999;340:409-417.